Pages that link to "Q53851542"

The following pages link to Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. (Q53851542):

Displaying 50 items.

• CD44 in rheumatoid arthritis (Q24804352) (← links)
• A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg (Q24805534) (← links)
• The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis (Q26774681) (← links)
• Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review (Q26774874) (← links)
• Inflammation induced loss of skeletal muscle (Q28083759) (← links)
• Regulation of innate responses during pre-patent schistosome infection provides an immune environment permissive for parasite development (Q31141885) (← links)
• The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards? (Q33782321) (← links)
• Etanercept: therapeutic use in patients with rheumatoid arthritis (Q33782355) (← links)
• The meteorology of cytokine storms, and the clinical usefulness of this knowledge (Q33867213) (← links)
• Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention (Q34001621) (← links)
• Etanercept (Enbrel): update on therapeutic use (Q34071287) (← links)
• Biologic therapies in rheumatoid arthritis (Q34108783) (← links)
• Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases (Q34450313) (← links)
• Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept (Q34595156) (← links)
• Current and future management approaches for rheumatoid arthritis (Q34731287) (← links)
• How does infliximab work in rheumatoid arthritis? (Q34731292) (← links)
• Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study). (Q34768442) (← links)
• Infliximab: 12 years of experience (Q35070446) (← links)
• Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells (Q35288713) (← links)
• Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis. (Q35550664) (← links)
• TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis (Q35553022) (← links)
• Metalloproteinases, inflammation, and rheumatoid arthritis. (Q35553483) (← links)
• Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice. (Q35554897) (← links)
• Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis (Q35609544) (← links)
• Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective (Q35834811) (← links)
• The use of anakinra in juvenile arthritis (Q36319606) (← links)
• TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications? (Q36361083) (← links)
• Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators (Q36364193) (← links)
• IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production (Q36562157) (← links)
• Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function (Q36776946) (← links)
• The Development of Novel Therapies for Rheumatoid Arthritis (Q36801049) (← links)
• Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis (Q37229283) (← links)
• Immune and inflammatory role in renal disease. (Q37243199) (← links)
• Clinical observations programme in SpA: disease parameters, treatment options and practical management issues (Q37279934) (← links)
• Evidence that cytokines play a role in rheumatoid arthritis (Q37316594) (← links)
• Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis (Q37421251) (← links)
• Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics (Q37443755) (← links)
• Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis (Q37607078) (← links)
• Autoimmunity and inflammation: murine models and translational studies (Q37891882) (← links)
• Macrophages in synovial inflammation (Q38008340) (← links)
• Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis (Q38018879) (← links)
• Inflammation and rheumatoid arthritis (Q38079456) (← links)
• Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists (Q38239111) (← links)
• Selected cytokine pathways in rheumatoid arthritis (Q38755912) (← links)
• The role of stromal cells in inflammatory bone loss (Q39248512) (← links)
• The Potential of Circadian Realignment in Rheumatoid Arthritis (Q39366944) (← links)
• Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells (Q39746551) (← links)
• Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures (Q39766387) (← links)
• The role of cytokines in rheumatoid arthritis. The Croonian Lecture 1995. (Q41170697) (← links)
• The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target (Q41265044) (← links)